#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Trigeminal neuralgia Squamous cell carcinoma of the cervix Aplastic anaemia Sickle cell disease Lip and/or oral cavity cancer Vascular malformation Crigler-Najjar syndrome Stress cardiomyopathy Severe myoclonic epilepsy of infancy Primary mediastinal large B-cell lymphoma Heavy menstrual bleeding HER2 gene amplification Neuroendocrine carcinoma metastatic Brain injury Aspergillus infection More trials…

    Learn about Rare Diseases

    Ewing’s sarcoma recurrent – Basic Information Gaucher’s disease type I Primary mediastinal large B-cell lymphoma – Diagnostics Primary immunodeficiency syndrome – Basic Information Glomerulonephritis membranous – Treatment Chronic granulomatous disease – Diagnostics Nodal marginal zone B-cell lymphoma – Treatment Turner’s syndrome – Diagnostics Haemophilia A with anti factor VIII – Basic Information Methylmalonic acidaemia – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Benzylpenicillin Sodium Dextran 70 Sodium Acetate (1-13C) Patiromer Tazobactam Sodium RIMIDUCID Formoterol Fumarate Jab-21822 Dazucorilant Messenger Rna Encoding Cas9 Rosuvastatin Zinc Sulodexide Flutamide Gadobutrol ANX007 Fingolimod Hydrochloride Dronedarone Riliprubart Namilumab Jnj-81241459 More therapies…

    Learn about Your Condition

    Organ donor Pleural mesothelioma malignant Strongyloidiasis Angina pectoris Breast cancer male Iron deficiency anaemia Rectal cancer stage II Notalgia paraesthetica Bacterial infection Low cardiac output syndrome Spondylolisthesis Thyroid mass Metachromatic leukodystrophy Cognitive disorder Colorectal adenoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Cardiovascular Diseases

  • Triple vs dual therapy with rosuvastatin, ezetimibe and bempedoic acid in patients with atherosclerotic heart disease and high cholesterol undergoing revascularisation

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Bempedoic Acid
    • Ezetimibe
    • Rosuvastatin
    Austria Germany

  • Phase 2 study of MK-7262 and enlicitide decanoate in adults with high lipoprotein(a)

    Recruiting

    2 1
    Denmark Germany The Netherlands Spain

  • Efficacy and Safety of BAY 3670549 in Adults with Atrial Fibrillation: A Randomized, Double‑Blind, Placebo‑Controlled Phase 2 Study

    Recruiting

    2 1
    Belgium Bulgaria Germany Hungary Italy The Netherlands +1

  • Spironolactone with drug combination to improve health in adults with Fontan circulation (clinical trial)

    Recruiting

    3 1 1
    Investigated Diseases:
    • Fontan procedure
    Investigated Drugs:
    • Spironolactone
    • [Al[18F]F]Fapi-74
    • Dapagliflozin
    Belgium

  • Effect of Lepodisiran on Coronary Plaque in Adults with Elevated Lipoprotein(a) and Established Atherosclerotic Cardiovascular Disease or High Risk for First Event

    Recruiting

    3 1
    Investigated Diseases:
    • Arteriosclerosis
    Investigated Drugs:
    • Ly3819469 Sodium
    Czechia Hungary The Netherlands Spain

  • Ticagrelor, Acetylsalicylic Acid and Prasugrel in Patients with Acute Coronary Syndrome: A Study of Antiplatelet Management

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Myocardial ischaemia
    Investigated Drugs:
    • Dipyridamole
    • Prasugrel Hydrobromide
    • Ticagrelor
    Norway Spain
1 2 3 … 128
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!